 |
 |
【參考文獻】
1 Robert W，Schrier MD，Wei Wang.Acute renal failure and sepsis.N Engl J Med,2004,351:159169.
2 Angus DC,LindeZwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care.Crit Care Med,2001,29:13031310.
3 Levy MM，Fink MP，Marshall JC，et al.SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference.Crit Care Med，2003，127:309315.
4 Schrier RW，Abraham WT.Hormones and hemodynamics in heart failure.N Engl J Med，1999,341:577585.
5 Boffa JJ,Arendshorst WJ.Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock.J Am Soc Nephrol,2005,16:117124.
6 閆振成，賈昆霞，張建國,等.內毒素脂多糖對培養(yǎng)腎小管上皮細胞凋亡和增殖的影響.第三軍醫(yī)大學學報，2002，23：12761278.
7 Yiping Wang,Gopala K Rangan,Brayan Goodwin,et al.Lipopolysaccharide induced MCP1 gene expression in rat tubuler epithelial cells is nuclear factorkappaB dependent.Kidney int,2000,57:20112022.
8 Flierl MA，Schreiber H，HuberLang MS.The role of complement，C5a and its receptors in sepsis and multiorgan dysfunction syndrome.J Invest Surg，2006,19:255265.
9 De Vriese AS.Prevention and treatment of acute renal failure in sepsis.J Am Soc Nephrol，2004,14:793805.
10 陳建，王翔，羅向東.內毒素與血管內皮細胞結合特異性初探.第三軍醫(yī)大學報，2003，11：2527.
11 李晶玲，王超.內毒素血癥時循環(huán)腎素血管緊張素改變的實驗研究.中國危重病急救醫(yī)學雜志，2006，18：9295.
12 Lemley KV.A basis for accelerated progression of diabetic nephropathy in pima indians.Kidney Int，2003,63:S38S42.
13 Kirkeboen KA,Strand A.The role of nitric oxide in sepsisan overview.Acta Anaesthesiol Scand,1999,43:275288.
14 Knotek M，Rogachev B，Wang W，et al.Endotoxemic renal failure in mice:role of tumor necrosis factor independent of inducible nitric oxide synthase.Kidney Int，2001，59 :22432249.
15 馬明，朱曉云，王立蓉，等.一氧化氮合酶對早期內毒素休克獼猴腎臟的影響.中國危重病急救醫(yī)學，2006，18：421424.
16 黃海華，范亞平，蔣季杰.誘導性一氧化氮合酶抑制劑在內毒素休克急性腎衰竭大鼠中的作用.中華腎臟病雜志，2002，18：299300.
17 O’mahony DS，Liles WS，Altermeier WA，et al.Mechanical ventilation interacts with endotoxemia to induce extrapulmonary organ dysfunction.Crit Care，2006,19:255265.
18 Aird WC.The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome.Blood，2003，101: 37653777.
19 Rivers E，Nguyen B，Havstad S，et al.Early goaldirected therapy in the treatment of severe sepsis and septic shock.N Engl J Med，2001,345:1368 1377.
20 何強，陳江華.膿毒癥的急性腎損傷.中華腎臟病雜志,2006,22:655657.
21 Kress JP,Pohlman AS,O’Connor MF,et al.Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.N Engl J Med，2000，42:14711477.
22 Finney SJ,Zekveld C,Elia A,et al.Glucose control and mortality in critically ill patients.JAMA，2003，290:20412047.
23 Annane D,Sebille V,Charpentier C,et al.Effect of treatment with low doses of hydrocortisone and fluidrocortisone on mortality in patients with septic shock.JAMA,2002,,288:862871.
24 Page B，VieillardBaron A，Chergui K,et al.Early venovenous baemodiariltration for sepsisrelated multiple organ failure.Critical care，2005,9:R755R763.
25 葛茂星，嚴剛.急性腎衰竭與膿毒癥.中國急救醫(yī)學，2005，25:208210.
26 Schiffl H，Lang SM，Fischer R.Daily hemodialysis and the outcome of acute renal failure.N Engl J Med，2002，346: 305310.
27 Russell JA.Management of sepsis.N Engl J Med，2006，355:16991713.
28 Yasuda H,Yuen PS,Hu X,et al.Simvastatin improves sepsisinduced mortality and acute kidney injury via renal vascular effects.Kidney Int，2006,69:15351542.
